loading page

Hospital-Acquired Venous Thromboembolism in Children with Sickle Cell Disease
  • +5
  • Shreya Agarwal,
  • Kayla L. Foster,
  • Shaniqua Johnson,
  • Mary Shapiro,
  • Hyojeong Han,
  • Michael Scheurer,
  • Gladstone Airewele,
  • Sarah E. Sartain
Shreya Agarwal
Nationwide Children's Hospital Hematology Oncology & Blood and Marrow Transplant

Corresponding Author:[email protected]

Author Profile
Kayla L. Foster
Baylor College of Medicine Department of Pediatrics
Author Profile
Shaniqua Johnson
Baylor College of Medicine Department of Pediatrics
Author Profile
Mary Shapiro
Baylor College of Medicine Department of Pediatrics
Author Profile
Hyojeong Han
Baylor College of Medicine Department of Pediatrics
Author Profile
Michael Scheurer
Texas Children's Cancer Center and Hematology Centers
Author Profile
Gladstone Airewele
Baylor College of Medicine Department of Pediatrics
Author Profile
Sarah E. Sartain
Baylor College of Medicine Department of Pediatrics
Author Profile

Abstract

Objectives: Sickle cell disease (SCD) is well recognized as a hypercoagulable state, however venous thromboembolism (VTE) risk factors in children remain largely unknown. In this study, we aim to describe the clinical characteristics, outcomes and recurrence of hospital acquired VTE in patients younger than 21 years of age. Study Design/Methods: Data were extracted from electronic medical records over a 10-year period (2011-2021). Data regarding sickle cell genotype, demographics, reason for admission, location of thrombus, presence of central venous catheter (CVC), intensive care unit (ICU) admission, presence of thrombophilia risk factors, resolution of VTE, mortality, and bleeding outcomes on anticoagulation were collected. Recurrence of VTE at 1 and 5 years was assessed. Descriptive statistics were used as indicated. Results: We identified a total of 21 VTE events over the ten-year study period. Six of these events occurred in those younger than 12 years of age. Fifteen (71%) VTE events occurred in the HbSS or HbSβThal 0 genotypes compared to 8 (29%) in HbSC. Eleven (52%) patients were admitted with acute chest syndrome (ACS). Most VTE events were associated with ICU admissions (n=13, 62%) and presence of central venous catheter (n=12, 57%). Major bleeding on anticoagulation occurred in 10%.All patients had resolution of index VTE at 12 weeks. Recurrence rate for VTE at 5 years was 13%. One patient died from the VTE event. Conclusions: Our study highlights that VTE can complicate SCD in children and young adults. Hospital acquired VTE were most associated with ICU admission, CVC, and ACS, but larger studies are indicated to validate our findings.
11 Feb 2023Submitted to Pediatric Blood & Cancer
11 Feb 2023Submission Checks Completed
11 Feb 2023Assigned to Editor
11 Feb 2023Review(s) Completed, Editorial Evaluation Pending
11 Feb 2023Reviewer(s) Assigned
09 Mar 2023Editorial Decision: Revise Major